News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
804,189 Results
Type
Article (72200)
Company Profile (725)
Press Release (731247)
Multimedia
Podcasts (173)
Webinars (29)
Section
Business (221073)
Career Advice (2946)
Deals (38238)
Drug Delivery (142)
Drug Development (87105)
Employer Resources (184)
FDA (17520)
Job Trends (16608)
News (374108)
Policy (35211)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2924)
Academic (2)
Accelerated approval (35)
Adcomms (27)
Allergies (157)
Alliances (55083)
ALS (185)
Alzheimer's disease (1810)
Antibody-drug conjugate (ADC) (356)
Approvals (17728)
Artificial intelligence (603)
Autoimmune disease (181)
Automation (42)
Bankruptcy (390)
Best Places to Work (12294)
BIOSECURE Act (23)
Biosimilars (205)
Biotechnology (449)
Bladder cancer (160)
Brain cancer (66)
Breast cancer (675)
Cancer (5140)
Cardiovascular disease (451)
Career advice (2498)
Career pathing (42)
CAR-T (312)
CDC (51)
Celiac Disease (1)
Cell therapy (838)
Cervical cancer (39)
Clinical research (73670)
Collaboration (1897)
Company closure (5)
Compensation (1209)
Complete response letters (77)
COVID-19 (2944)
CRISPR (103)
C-suite (940)
Cystic fibrosis (154)
Data (6496)
Decentralized trials (2)
Denatured (62)
Depression (156)
Diabetes (534)
Diagnostics (7188)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (296)
Drug pricing (217)
Drug shortages (33)
Duchenne muscular dystrophy (249)
Earnings (93578)
Editorial (67)
Employer branding (24)
Employer resources (165)
Events (127998)
Executive appointments (1060)
FDA (20789)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1596)
Gene editing (222)
Generative AI (60)
Gene therapy (680)
GLP-1 (1116)
Government (4777)
Grass and pollen (8)
Guidances (386)
Healthcare (20063)
HIV (66)
Huntington's disease (51)
IgA nephropathy (89)
Immunology and inflammation (296)
Immuno-oncology (71)
Indications (122)
Infectious disease (3243)
Inflammatory bowel disease (214)
Inflation Reduction Act (17)
Influenza (127)
Intellectual property (263)
Interviews (551)
IPO (17662)
IRA (59)
Job creations (4720)
Job search strategy (2064)
JPM (67)
Kidney cancer (17)
Labor market (86)
Layoffs (648)
Leadership (42)
Legal (8761)
Liver cancer (98)
Longevity (16)
Lung cancer (689)
Lymphoma (390)
Machine learning (44)
Management (64)
Manufacturing (877)
MASH (178)
Medical device (14839)
Medtech (14901)
Mergers & acquisitions (21672)
Metabolic disorders (1408)
Multiple sclerosis (174)
NASH (20)
Neurodegenerative disease (371)
Neuropsychiatric disorders (105)
Neuroscience (3189)
Neurotech (1)
NextGen: Class of 2026 (7233)
Non-profit (4797)
Now hiring (69)
Obesity (679)
Opinion (339)
Ovarian cancer (171)
Pain (221)
Pancreatic cancer (245)
Parkinson's disease (307)
Partnered (38)
Patents (534)
Patient recruitment (522)
Peanut (63)
People (64741)
Pharmaceutical (134)
Pharmacy benefit managers (31)
Phase 1 (22945)
Phase 2 (32235)
Phase 3 (24190)
Pipeline (5660)
Policy (322)
Postmarket research (2966)
Preclinical (10227)
Press Release (72)
Prostate cancer (255)
Psychedelics (59)
Radiopharmaceuticals (308)
Rare diseases (954)
Real estate (6887)
Recruiting (79)
Regulatory (26460)
Reports (47)
Research institute (2720)
Resumes & cover letters (446)
Rett syndrome (28)
RNA editing (20)
RSV (88)
Schizophrenia (165)
Series A (265)
Series B (204)
Service/supplier (27)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (48)
Startups (4179)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (97)
The Weekly (109)
Vaccines (1143)
Venture capital (101)
Weight loss (463)
Women's health (98)
Worklife (22)
Date
Today (168)
Last 7 days (732)
Last 30 days (2541)
Last 365 days (31948)
2026 (4448)
2025 (32257)
2024 (37581)
2023 (42322)
2022 (53681)
2021 (58226)
2020 (56789)
2019 (49671)
2018 (37821)
2017 (35856)
2016 (36206)
2015 (42507)
2014 (36594)
2013 (32657)
2012 (33688)
2011 (33713)
2010 (32157)
Location
Africa (1042)
Alabama (94)
Alaska (7)
Arizona (303)
Arkansas (15)
Asia (49040)
Australia (8361)
California (11882)
Canada (3393)
China (1200)
Colorado (497)
Connecticut (517)
Delaware (357)
Europe (109459)
Florida (1763)
Georgia (377)
Hawaii (4)
Idaho (66)
Illinois (934)
India (77)
Indiana (561)
Iowa (24)
Japan (454)
Kansas (133)
Kentucky (45)
Louisiana (29)
Maine (82)
Maryland (1458)
Massachusetts (8731)
Michigan (359)
Minnesota (674)
Mississippi (5)
Missouri (144)
Montana (35)
Nebraska (29)
Nevada (128)
New Hampshire (87)
New Jersey (3186)
New Mexico (33)
New York (3140)
North Carolina (1634)
North Dakota (9)
Northern California (5747)
Ohio (363)
Oklahoma (22)
Oregon (53)
Pennsylvania (2368)
Puerto Rico (25)
Rhode Island (51)
South America (1414)
South Carolina (70)
South Dakota (1)
Southern California (4590)
Tennessee (181)
Texas (1828)
United States (42584)
Utah (354)
Vermont (1)
Virginia (297)
Washington D.C. (86)
Washington State (992)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
804,189 Results for "yeda research and development company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile
January 22, 2026
·
13 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
IN PARTNERSHIP WITH TAKEDA
Takeda’s Commitment to Trial Representation is Shaping the Future of Clinical Research
One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical trials. Two employees from its research and development organization discuss why representation matters and the work their team is doing to benefit patients now and in the future.
January 5, 2026
·
5 min read
·
BioSpace Insights
Press Releases
InterAx and Alveus Announce Strategic Research and Licensing Agreement to Develop Differentiated Therapeutic Candidate for Metabolic Disease
January 16, 2026
·
2 min read
Job Trends
12 Companies Hiring R&D Professionals Now
Looking for a research and development job? Check out the
BioSpace
list of 12 companies hiring life sciences professionals like you.
January 22, 2026
·
2 min read
·
Angela Gabriel
Sponsored
Disruptive Innovation in Cancer Research: The New Era of Oncology
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.
December 15, 2025
·
9 min read
Bio NC
CoImmune, Inc. Announces Research Collaboration with Yeda Research and Development Company Ltd.
CoImmune, Inc. announced a research collaboration with Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science, to evaluate the applications of the Synthetic Immune Niche technology, developed by Weizmann Institute’s researchers to enhance the expansion and function of human cytokine induced killer cells expressing chimeric antigen receptors.
November 17, 2021
·
3 min read
Press Releases
ProImmune Ltd Introduces ProVE® SL Self‑Loading MHC Class I Monomers to Improve T Cell Research Flexibility
October 30, 2025
·
2 min read
Press Releases
Ethris and German Center for Infection Research (DZIF) Announce Strategic Collaboration to Develop mRNA-Based Vaccines
February 9, 2026
·
4 min read
Press Releases
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
February 18, 2026
·
5 min read
1 of 80,419
Next